Glycosaminoglycans synthesized by cultured bovine corneal endothelial cells.
Bovine corneal endothelial (BCE) cells seeded and grown on plastic dishes were labeled with 35S-sulfate or 3H-glucosamine for 48 h at various phases of growth of the cultures. Newly synthesized proteoglycans were isolated from the culture medium and from the extracellular matrix (ECM) produced by the BCE cells, and the glycosaminoglycan (GAG) component of the proteoglycans was analyzed. Cells actively proliferating on plastic surfaces secreted an ECM that contained heparan sulfate as the major 35S-labeled GAG (86%) and dermatan sulfate as a minor component (13%). Upon reaching confluence, the BCE cells incorporated 35S-labeled chondroitin sulfate (20%), as well as heparan sulfate (66%) and dermatan sulfate (14%), into the EC. Seven-day postconfluent cells incorporated newly synthesized heparan sulfate and dermatan sulfate into the matrix in approximately equal proportions. Dermatan sulfate was the main 35S-labeled GAG (60-65%) in the medium of both confluent and postconfluent cultures. 35S-Labeled chondroitin sulfate (20-25%) and heparan sulfate (15%) were also secreted into the culture medium. The type of GAG incorporated into newly synthesized ECM was affected when BCE cells were seeded onto ECM-coated dishes instead of plastic. BCE cells actively proliferating on ECM-coated dishes incorporated newly synthesized heparan sulfate and dermatan sulfate into the ECM in a ratio that was very similar to the ratio of these GAGs in the underlying ECM. Addition of mitogens such as fibroblast growth factor (FGF) to the culture medium altered the type of GAG synthesized and incorporated into the ECM by BCE cells seeded onto ECM-coated dishes if the cells were actively growing, but had no effect on postconfluent cultures.
D000818:Animals; D002417:Cattle; D002455:Cell Division; D002478:Cells, Cultured; D002809:Chondroitin Sulfates / Q000032:analysis; D002850:Chromatography, Gel; D003315:Cornea; D003871:Dermatan Sulfate / Q000096:biosynthesis; D004727:Endothelium / Q000166:cytology* / Q000378:metabolism; D005109:Extracellular Matrix / Q000378:metabolism*; D005346:Fibroblast Growth Factors / Q000494:pharmacology; D006025:Glycosaminoglycans / Q000032:analysis / Q000096:biosynthesis*; D006133:Growth Substances / Q000494:pharmacology; D006497:Heparan Sulfate / Q000096:biosynthesis; D011509:Proteoglycans / Q000032:analysis
D002809:Chondroitin Sulfates; D003871:Dermatan Sulfate; D005346:Fibroblast Growth Factors; D006025:Glycosaminoglycans; D006133:Growth Substances; D006497:Heparan Sulfate; D011509:Proteoglycans